Form 8-K - Current report:
SEC Accession No. 0001140361-25-006659
Filing Date
2025-03-03
Accepted
2025-03-03 08:00:39
Documents
44
Period of Report
2025-03-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20044669_8k.htm   iXBRL 8-K 31793
2 EXHIBIT 99.1 ef20044669_ex99-1.htm EX-99.1 60938
6 ef20044669_ex99-1slide1.jpg GRAPHIC 78131
7 ef20044669_ex99-1slide2.jpg GRAPHIC 412885
8 ef20044669_ex99-1slide3.jpg GRAPHIC 137329
9 ef20044669_ex99-1slide4.jpg GRAPHIC 172850
10 ef20044669_ex99-1slide5.jpg GRAPHIC 150896
11 ef20044669_ex99-1slide6.jpg GRAPHIC 176253
12 ef20044669_ex99-1slide7.jpg GRAPHIC 140971
13 ef20044669_ex99-1slide8.jpg GRAPHIC 176286
14 ef20044669_ex99-1slide9.jpg GRAPHIC 139218
15 ef20044669_ex99-1slide10.jpg GRAPHIC 153056
16 ef20044669_ex99-1slide11.jpg GRAPHIC 92770
17 ef20044669_ex99-1slide12.jpg GRAPHIC 74388
18 ef20044669_ex99-1slide13.jpg GRAPHIC 142287
19 ef20044669_ex99-1slide14.jpg GRAPHIC 116416
20 ef20044669_ex99-1slide15.jpg GRAPHIC 90468
21 ef20044669_ex99-1slide16.jpg GRAPHIC 80850
22 ef20044669_ex99-1slide17.jpg GRAPHIC 103061
23 ef20044669_ex99-1slide18.jpg GRAPHIC 147848
24 ef20044669_ex99-1slide19.jpg GRAPHIC 156910
25 ef20044669_ex99-1slide20.jpg GRAPHIC 142803
26 ef20044669_ex99-1slide21.jpg GRAPHIC 97946
27 ef20044669_ex99-1slide22.jpg GRAPHIC 74378
28 ef20044669_ex99-1slide23.jpg GRAPHIC 184650
29 ef20044669_ex99-1slide24.jpg GRAPHIC 154765
30 ef20044669_ex99-1slide25.jpg GRAPHIC 151631
31 ef20044669_ex99-1slide26.jpg GRAPHIC 132186
32 ef20044669_ex99-1slide27.jpg GRAPHIC 208145
33 ef20044669_ex99-1slide28.jpg GRAPHIC 79043
34 ef20044669_ex99-1slide29.jpg GRAPHIC 189573
35 ef20044669_ex99-1slide30.jpg GRAPHIC 205130
  Complete submission text file 0001140361-25-006659.txt   6257670

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA grce-20250303.xsd EX-101.SCH 3976
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE grce-20250303_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grce-20250303_pre.xml EX-101.PRE 16040
46 EXTRACTED XBRL INSTANCE DOCUMENT ef20044669_8k_htm.xml XML 4232
Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-322-1602
Grace Therapeutics, Inc. (Filer) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-35776 | Film No.: 25693835
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)